Dr. Parijatham Thomas, MD

Claim this profile

M D Anderson Cancer Center

Studies Ductal Carcinoma In Situ
Studies Breast cancer
2 reported clinical trials
4 drugs studied

Area of expertise

1Ductal Carcinoma In Situ
Parijatham Thomas, MD has run 2 trials for Ductal Carcinoma In Situ. Some of their research focus areas include:
Stage I
HER2 positive
PR positive
2Breast Cancer
Parijatham Thomas, MD has run 2 trials for Breast cancer. Some of their research focus areas include:
Stage I
HER2 positive
PR positive

Affiliated Hospitals

Image of trial facility.
M D Anderson Cancer Center
Image of trial facility.
University Of Texas MD Anderson Cancer Center

More about Parijatham Thomas, MD

Clinical Trial Related7 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 0 Active Clinical Trials
Treatments Parijatham Thomas, MD has experience with
  • Metformin Hydrochloride Extended Release
  • Nightly Fasting
  • Ruxolitinib
  • Surgery

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Parijatham Thomas, MD specialize in?
Is Parijatham Thomas, MD currently recruiting for clinical trials?
Are there any treatments that Parijatham Thomas, MD has studied deeply?
What is the best way to schedule an appointment with Parijatham Thomas, MD?
What is the office address of Parijatham Thomas, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security